Hollywood Shock: Perry’s Supplier Gets 15 Years

Close-up of a locked jail cell door with a key inserted

A Hollywood “elite” drug pipeline just met a hard federal wall, and the message is simple: selling lethal narcotics has consequences—even when the customer is famous.

Story Snapshot

Jasveen Sangha, known as the “Ketamine Queen,” was sentenced to 15 years in federal prison for illegally distributing ketamine tied to Matthew Perry’s 2023 death.
Federal prosecutors argued Sangha kept dealing even after learning her supply was linked to earlier deaths, while her attorneys sought time served based on jail behavior.
Judge Sherilyn Peace Garnett imposed the full 15-year term plus three years of supervised release, rejecting a lighter sentence.
The case remains active, with additional defendants—including Perry’s assistant and an alleged middleman—scheduled for sentencing later in April 2026.

Federal sentencing brings a clear verdict on a lethal supply chain

Federal court in Los Angeles sentenced Jasveen Sangha to 15 years in prison and three years of supervised release after she pleaded guilty to five federal charges tied to illegally distributing ketamine that resulted in the death of actor Matthew Perry. The sentencing closes one major chapter in a case that has drawn national attention because it involves a celebrity, but the underlying facts mirror a broader American reality: illegal drug networks often operate through layers of suppliers and facilitators.

Prosecutors described Sangha as a specialist ketamine dealer who marketed herself to wealthier clientele, a detail that resonates beyond Hollywood because it shows how drug trafficking adapts to different markets. According to reporting on the case, Sangha sold 25 vials of ketamine on October 24, 2023, for $6,000 to Perry’s representatives, and Perry was found dead days later on October 28, 2023, in a hot tub at his Pacific Palisades home. Investigators then widened their focus to the full distribution network.

What the judge and both sides argued in court

Judge Sherilyn Peace Garnett imposed the full 15-year prison sentence that prosecutors sought, and she told Sangha she would need to show “epic resilience” during incarceration. Sangha’s defense lawyers urged the court to consider a far lighter outcome, arguing for time served and pointing to what they characterized as exemplary conduct while she was jailed awaiting sentencing. The judge ultimately rejected that recommendation, choosing a punishment aligned with the government’s assessment of the offense’s severity.

The prosecution’s position mattered because it went beyond a single transaction and addressed alleged pattern behavior. Prosecutors emphasized reporting that Sangha continued distributing drugs even after learning her supply had contributed to previous deaths, which they argued showed a lack of remorse and an ongoing threat to the public. That framing helps explain why the court sided with the government’s request rather than granting leniency, even though the defense highlighted her behavior as an inmate.

More defendants remain, underscoring how these networks function

Sangha is the third of five defendants to be sentenced, and the remaining sentencings are expected to keep attention on who did what inside the chain between supplier and end user. Kenneth Iwamasa, Perry’s personal assistant, is scheduled for sentencing on April 22, 2026, and faces up to 15 years. Erik Fleming, described as a middleman coordinating sales between Sangha and Iwamasa, is scheduled for sentencing on April 29, 2026, and faces up to 25 years.

Why this matters beyond Hollywood: accountability, deterrence, and government competence

Public frustration with government often centers on a basic question: can institutions protect ordinary people and enforce the law fairly, or do the connected get special treatment? This sentencing signals that federal prosecutors and the court were willing to pursue a high-profile case through to a substantial prison term. For conservatives who prioritize law-and-order and equal accountability, the outcome reads as a deterrence-focused approach, not a “catch and release” mindset that many voters associate with softer criminal-justice trends.

At the same time, the case highlights how drug access can slip through informal channels that exist alongside legitimate medical use and regulation. The reporting indicates investigators treated Perry’s death not as an isolated tragedy but as a network problem involving suppliers and intermediaries. The next key test is consistency: whether the remaining defendants’ sentencings match the government’s stated goal of holding each link accountable. The public record cited here does not detail every charge against the remaining defendants, so readers should watch those court outcomes closely.